Effects of Cardiovascular Health Education Program on Community-dwelling Older Adults at Risk of ASCVD
- Conditions
- Cardiovascular DiseasesHealthy LifestyleHealth Education
- Interventions
- Behavioral: HE programmeBehavioral: Usual care
- Registration Number
- NCT05031377
- Lead Sponsor
- The Hong Kong Polytechnic University
- Brief Summary
Despite older adults being exposed to an increased risk of atherosclerotic cardiovascular disease (ASCVD), they are generally underrepresented in cardiovascular prevention programmes. The aim of this study is to assess the feasibility of implementing an integrated exercise and cardiovascular health education programme (HE programme) on older adults at risk of ASCVD.
- Detailed Description
The study is a two-arm pilot randomized controlled trial. (1) The control group will receive a basic lifestyle modification talk and governmental education leaflets. (2) The experimental group will receive an integrated exercise and health education programme (HE programme) based on self-efficacy theory. Physical activity level, exercise self-efficacy and ASCVD risk profile including blood pressure, cardiac endurance, and anthropometric outcomes will be investigated via physiological assessments, medical history-taking or questionnaires at baseline, Week 6, and Week 12. Meanwhile, study feasibility will be primarily evaluated in terms of programme acceptability, intervention integrity, recruitment rate and retention rate throughout the process and at Week 12.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 80
- Chinese adults ≧60 years old
- Having at least one ASCVD risk factor
- Pass the cardiovascular fitness evaluation
- Able to write and read Chinese, and communicate in Cantonese;
- Possess a mobile phone and able to make use of the phone in reading SMS
- Visually impaired, hearing impaired, or suffer from cognitive, psychiatric, or muscular disorder
- Having a history of attending similar cardiovascular prevention program
- Having a previous history of coronary heart disease or stroke
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Experimental Arm: Integrated Intervention HE programme Receive an integrated exercise and cardiovascular health education programme (HE programme) Control Usual care Receive usual care
- Primary Outcome Measures
Name Time Method Physical activity level (classification of physical activity level) At baseline, at Week 6, and at Week 12 The physical activity level will be measured by the Chinese version of International Physical Activity Questionnaire-short form (IPAQ-C-short form). Participants are classified into "inactive", "minimally active" or "health enhancing physical activity (HEPA) active" based on their physical activity levels.
Physical activity level (total score) At baseline, at Week 6, and at Week 12 The physical activity level will be measured by the Chinese Version of Physical Activity Scale for the Elderly (PASE-C). The total score (from zero to 400 or above) is quantified based on frequency values and weights for these activities. The higher the score, the higher the level of physical activity.
- Secondary Outcome Measures
Name Time Method Acceptability of the program to outcome assessors After the outcome assessors have finished their duties It will be measured by a self-developed questionnaire completed by outcome assessors
Acceptability of the program to lecture deliverers After the lecture deliverers have finished their duties It will be measured by a self-developed questionnaire completed by lecture deliverers
Exercise self-efficacy At baseline, at Week 6, and at Week 12 Exercise self-efficacy will be measured via the Chinese version of Self-Efficacy for Exercise (SEE-C). The total score ranges from 0 to 90. The higher the score, the greater the exercise self-efficacy.
ASCVD risk profiles (Blood pressure, weight, height, BMI & waist circumference, heart rate) At baseline, at Week 6, and at Week 12 The ASCVD risk profiles will be assessed by physical evaluations carried out by blinded, trained outcome assessors.
ASCVD risk profiles (2-minute walk test) At screening stage, at Week 6, and at Week 12 2-minute walk test will be adopted to examine aerobic capacity and self-paced walking capacity by measuring the walking distance covered at two minutes. It will be assessed by blinded, trained outcome assessors.
Adverse events throughout the program Throughout the study period Unfavorable or unintended events regarding the programme reported by participants throughout the study period.
Eligibility rate At baseline The number of eligible potential participants divided by the number of screened people
Questionnaire completion rate At baseline, at Week 6 and at Week 12 The number of participants who complete the questionnaire divided by the number of distributed questionnaires
Acceptability of the program to participants At Week 12 It will be measured by a self-developed questionnaire
Recruitment rate At baseline The percentage of participants who consent to join the study and being recruited
Program safety evaluated by participants At Week 12 It will be measured via a self-developed questionnaire completed by participants
Retention rate At baseline, at Week 6 and at Week 12 The percentage of participants remaining in the study
Adherence to intervention At Week 6 and at Week 12 * The number of participants in the experimental group who practice the tailor-made exercise learned during the intervention divided by the number of participants in the experimental group
* Experimental group's frequency in performing tailor-made exercise related to the recommended exercise dosageMissing data At baseline, at Week 6 and at Week 12 The percentage of missing data
Lecture attendance rate Immediately after education session * The number of participants in the control group who attend the education talk divided by the number of participants who are randomized into the control group
* The number of participants in the experimental group who attend the education session divided by the number of participants who are randomized into the experimental group
* The number of participants in the two groups who attend the education session divided by the number of randomized participantsAttendance rate to data collection At baseline, at Week 6 and at Week 12 * The number of participants in the control group who attend the data collection divided by the number of participants who are randomized into the control group
* The number of participants in the experimental group who attend the data collection divided by the number of participants who are randomized into the experimental group
* The number of participants who attend the data collection divided by the number of randomized participantsStructured questionnaire At baseline The questionnaire will primarily include patient demographics, medical history, lifestyle patterns, medication use and physical fitness evaluation data, etc.